Showing results (341-350 of 387) with videos related to

Sort By:
Pageof 39
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 studyEvelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The Lancet. Infectious Diseases|January 11, 2024
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trialMaria Ubals, Patricia Nadal-Baron, Maider Arando, et al.
Blood Advances|December 14, 2022
Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemiaChaitra Ujjani, Ted A Gooley, Stephen E Spurgeon, et al.
Pathogens & Immunity|May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 13, 2023
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort studyPaul K Drain, Ronit R Dalmat, Linhui Hao, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Variant mutation in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidationHannah C Kubinski, Hannah W Despres, Bryan A Johnson, et al.
Annals of the American Thoracic Society|March 1, 2023
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop ReportGuang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Open Forum Infectious Diseases|September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody TherapyRinki Deo, Manish C Choudhary, Owen T Glover, et al.
Molecular Therapy. Methods & Clinical Development|January 21, 2021
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized miceDaniel Stone, Kelly R Long, Michelle A Loprieno, et al.
Pageof 39